Project Details
Description
Project Narrative
Spinal muscular atrophy (SMA) is a frequently fatal motor neuron disorder caused by low SMN protein, and
although raising SMN levels appears to benefit patients, very little is known about how the protein protects the
motor neurons or if restricted delivery of currently available SMA drugs to these cells suffices as a cure. Here
we wish to investigate these vitally important questions. Our research will result in a better understanding of
the biology of SMA and is thus expected to inform newer treatments for this and similar motor neuron
disorders.
Status | Finished |
---|---|
Effective start/end date | 12/15/18 → 11/30/22 |
Funding
- National Institute of Neurological Disorders and Stroke: US$356,984.00
- National Institute of Neurological Disorders and Stroke: US$356,984.00
- National Institute of Neurological Disorders and Stroke: US$384,491.00
ASJC Scopus Subject Areas
- Clinical Neurology
- Neurology
- Genetics
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.